Niefind, K.; Bischoff, N.; Golub, A.G.; Bdzhola, V.G.; Balanda, A.O.; Prykhod’ko, A.O.; Yarmoluk, S.M.
Structural Hypervariability of the Two Human Protein Kinase CK2 Catalytic Subunit Paralogs Revealed by Complex Structures with a Flavonol- and a Thieno[2,3-d]pyrimidine-Based Inhibitor. Pharmaceuticals 2017, 10, 9.
https://doi.org/10.3390/ph10010009
AMA Style
Niefind K, Bischoff N, Golub AG, Bdzhola VG, Balanda AO, Prykhod’ko AO, Yarmoluk SM.
Structural Hypervariability of the Two Human Protein Kinase CK2 Catalytic Subunit Paralogs Revealed by Complex Structures with a Flavonol- and a Thieno[2,3-d]pyrimidine-Based Inhibitor. Pharmaceuticals. 2017; 10(1):9.
https://doi.org/10.3390/ph10010009
Chicago/Turabian Style
Niefind, Karsten, Nils Bischoff, Andriy G. Golub, Volodymyr G. Bdzhola, Anatoliy O. Balanda, Andriy O. Prykhod’ko, and Sergiy M. Yarmoluk.
2017. "Structural Hypervariability of the Two Human Protein Kinase CK2 Catalytic Subunit Paralogs Revealed by Complex Structures with a Flavonol- and a Thieno[2,3-d]pyrimidine-Based Inhibitor" Pharmaceuticals 10, no. 1: 9.
https://doi.org/10.3390/ph10010009
APA Style
Niefind, K., Bischoff, N., Golub, A. G., Bdzhola, V. G., Balanda, A. O., Prykhod’ko, A. O., & Yarmoluk, S. M.
(2017). Structural Hypervariability of the Two Human Protein Kinase CK2 Catalytic Subunit Paralogs Revealed by Complex Structures with a Flavonol- and a Thieno[2,3-d]pyrimidine-Based Inhibitor. Pharmaceuticals, 10(1), 9.
https://doi.org/10.3390/ph10010009